Mitsuki Tabata
Overview
Explore the profile of Mitsuki Tabata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tabata M, Tsubaki M, Takeda T, Tateishi K, Tsurushima K, Imano M, et al.
BMC Complement Med Ther
. 2020 Mar;
20(1):84.
PMID: 32171300
Background: Current chemotherapies for Burkitt lymphoma (BL) have dramatically improved its clinical outcome. However, chemoresistance can lead to chemotherapy failure and very poor prognosis; thus, novel strategies are urgently required...
2.
Tabata M, Tsubaki M, Takeda T, Tateishi K, Maekawa S, Tsurushima K, et al.
Clin Exp Med
. 2019 Oct;
20(1):63-71.
PMID: 31650359
Multiple myeloma (MM) is the second most common hematologic malignancy. In spite of the development of new therapeutic agents, MM remains incurable due to multidrug resistance (MDR) and the 5-year...
3.
Tsubaki M, Takeda T, Obata N, Kawashima K, Tabata M, Imano M, et al.
J Cell Physiol
. 2019 Mar;
234(10):17975-17989.
PMID: 30834527
Malignant melanoma is a highly aggressive skin cancer, and the overall median survival in patients with metastatic melanoma is only 6-9 months. Although molecular targeted therapies have recently been developed...